| 000 | 01258 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516072923.0 | ||
| 264 | 0 | _c20130718 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1477-092X | ||
| 024 | 7 |
_a10.1177/1078155211433231 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcDonnell, A M | |
| 245 | 0 | 0 |
_aSuspected serotonin syndrome in a patient being treated with methylene blue for ifosfamide encephalopathy. _h[electronic resource] |
| 260 |
_bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _cDec 2012 |
||
| 300 |
_a436-9 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aBrain Diseases _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIfosfamide _xadverse effects |
| 650 | 0 | 4 |
_aMethylene Blue _xadverse effects |
| 650 | 0 | 4 |
_aSerotonin Syndrome _xchemically induced |
| 700 | 1 | _aRybak, I | |
| 700 | 1 | _aWadleigh, M | |
| 700 | 1 | _aFisher, D C | |
| 773 | 0 |
_tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _gvol. 18 _gno. 4 _gp. 436-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/1078155211433231 _zAvailable from publisher's website |
| 999 |
_c21451723 _d21451723 |
||